Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) posted Other Non Operating Income of $35000.0 for Q1 2026, down 95.01% on a QoQ basis from $701000.0 in Q4 2025, and up 266.67% year-over-year from $9545.5 in Q1 2025.
Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $35000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 266.67% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (down 46.18% YoY) and the FY2025 annual result came in at $382000.0, down 97.49% from the prior year.
- Other Non Operating Income was $35000.0 for Q1 2026 at Arcturus Therapeutics Holdings, down from $701000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $34.0 million in Q1 2023 and bottomed at -$34.2 million in Q4 2023.
- A 5-year average of $456294.1 and a median of $4000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income jumped 6120.04% — and 2024, when it slumped 5125.0%.
- Arcturus Therapeutics Holdings' Other Non Operating Income stood at -$3.8 million in 2022, then slumped by 791.32% to -$34.2 million in 2023, then jumped by 109.4% to $3.2 million in 2024, then sank by 78.19% to $701000.0 in 2025, then slumped by 95.01% to $35000.0 in 2026.
- Business Quant data shows ARCT's Other Non Operating Income at $35000.0 in Q1 2026, $701000.0 in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Sep 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | -127,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | -201,000.00 |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | -53,000.00 |
| Dec 31, 2023 | -34.18 Mn |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 149,000.00 |
| Mar 31, 2023 | 33.95 Mn |
| Dec 31, 2022 | -3.84 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | -560,000.00 |
| Mar 31, 2022 | -564,000.00 |
| Dec 31, 2021 | -2.84 Mn |
| Sep 30, 2021 | -519,000.00 |
| Jun 30, 2021 | -13,000.00 |